Table 2.
Timing of uveitis | Cohort 1 | Cohort 2 | p‐value * |
---|---|---|---|
<2010 | ≥2010 | ||
At diagnosis | |||
Number of eyes | 109 | 133 | |
Posterior synechiae, n (%) | 24 (22) | 24 (18) | 0.44 |
Cataract surgery, n (%) | 0 (0) | 0 (0) | NA |
Ocular hypertension, n (%) | 6 (6) | 18 (14) | 0.04 |
Secondary glaucoma, n (%) | 1 (1) | 0 (0) | 0.45 |
Glaucoma surgery, n (%) | 0 (0) | 1 (1) | 1.00 |
CME, (%) | 2 (2) | 6 (5) | 0.30 |
Papillitis, n (%) | 5 (5) | 8 (6) | 0.62 |
Hypotony, n (%) | 0 (0) | 0 (0) | NA |
Follow‐up at 5 years | |||
Number of eyes | 105 | 76 | |
Posterior synechiae, n (%) | 47 (45) | 22 (29) | 0.03 |
Cataract surgery, n (%) | 42 (40) | 15 (20) | 3.79 × 10−3 |
Secondary glaucoma, n (%) | 22 (21) | 8 (10) | 0.06 |
Glaucoma surgery, n (%) | 25 (24) | 10 (13) | 0.07 |
CME, (%) | 20 (19) | 9 (12) | 0.19 |
Papillitis, n (%) | 16 (15) | 15 (20) | 0.43 |
Hypotony, n (%) | 3 (4) | 0 (0) | 1.00 |
Analysis performed by “eye”.
CME = cystoid macular oedema, NA = not applicable.
The Pearson χ 2 test or Fisher exact test.